Recently, a meta-analysis study suggested that the SNP +276G/T of ADIPOQ gene is a low risk factor for development of cardiovascular disease in T2DM; however, the association of this polymorphism with the susceptibility to cardiovascular disease in other populations remains unknown[22]. This evidence concerns the gene ADIPOQ and cardiovascular disorder.